FindTrial
Sign In

Lung Function Test in Post Covid patients: An Observational Study.

Lung Function Indices Measured by Forced Oscillation Test in Post Covid patients: An Observational Study.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/01/030235
Enrollment
50
Registered
2021-01-05
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere Health Condition 2: J841- Other interstitial pulmonary diseases with fibrosis

Interventions

None listed

Sponsors

Dr Nagesh Dhadge
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Participant who is willing to provide written informed consent. 2. Male and female patients (age- 5 years to 80 years ) who have had tested positive for COVID19 on polymer chain reaction test (PCR) or rapid antigen test and recovered

Exclusion criteria

Exclusion criteria: 1. Pregnant women. 2. Participant unwilling to sign an informed consent form 3. Patients with purulent sputum, oxygen saturation less than 90, patients on supplemental oxygen. 4. Those having signs of active lower respiratory tract infection on clinical examination. 5. Those who cannot perform lung function test, patients having active chest pain. 6. Haemoptysis of unknown origin, pneumothorax, unstable angina pectoris, myocardial infarction, thoracic aneurysms, abdominal aneurysms, cerebral aneurysms, recent eye surgery (within 2 weeks due to increased intra ocular pressure during forced expiration), abdominal or thoracic surgical procedures within past 1 month, and patients with a history of syncope associated with forced exhalation.

Design outcomes

Primary

MeasureTime frame
What are the characteristics of resistance and reactance measured by FOT in post COVID-19 period after discharge and on further follow up after one month?Timepoint: 0 and 1 month—

Secondary

MeasureTime frame
1)To measure - Resistance R5, R20, R5-R20 and reactance X5, X20, X inspiratory-X expiratory) by FOT. 2)Oxygen saturation (SPO2), dyspnoea scale in the first 50 COVID-19 patients visiting for the first follow up to the CGHS wellness center after discharge and further at one month follow-up. 3)To correlate FOT indices with the blood markers like C reactive protein, D-Dimer, lymphocyte count, radiological findings (CXR and HRCT), oxygen done at the time of hospitalization and mMRC dyspnoea score. Timepoint: 0 and 1 month—

Countries

India

Contacts

Public ContactDr Nagesh Dhadge

Central Health Services, Pune.India

ndhadge@hotmail.com9822327445

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026